Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -116.95% is 64% above its 5-year average of -324.52%, near the high end of its 5-year range (-1214.98%–-88.34%).
7.19% below its 12-month average of -109.11%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -88.34%.
OPERATING MARGIN
-116.95%
OPERATING MARGIN AVG TTM
-109.11%
OPERATING MARGIN AVG 3Y
-183.65%
OPERATING MARGIN AVG 5Y
-324.52%
OPERATING MARGIN AVG 10Y
-322.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-7.19%
CURRENT VS 3Y AVG
+36.32%
CURRENT VS 5Y AVG
+63.96%
CURRENT VS 10Y AVG
+63.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bionano Genomics, Inc.
Market Cap
$16.75M
Operating Margin
-116.95%
TTM Avg
-109.11%
3Y Avg
-183.65%
5Y Avg
-324.52%
Market Cap
$16.76M
Operating Margin
-65.74%
TTM Avg
-32.87%
3Y Avg
-308.88%
5Y Avg
2329.03%
Market Cap
$16.53M
Operating Margin
-1315.38%
TTM Avg
-3051.53%
3Y Avg
-1759.85%
5Y Avg
-1656.14%
Market Cap
$17.04M
Operating Margin
-30712.68%
TTM Avg
-16099.03%
3Y Avg
-14791.19%
5Y Avg
-11673.89%
Market Cap
$16.40M
Operating Margin
-579.88%
TTM Avg
-374.35%
3Y Avg
-344.88%
5Y Avg
-436.34%
Market Cap
$17.11M
Operating Margin
-524.69%
TTM Avg
-267.50%
3Y Avg
-582.47%
5Y Avg
-385.07%
Market Cap
$17.17M
Operating Margin
0.00%
TTM Avg
-84.34%
3Y Avg
-293.08%
5Y Avg
-1756.66%
Market Cap
$15.93M
Operating Margin
0.00%
TTM Avg
-6897.41%
3Y Avg
-4279.04%
5Y Avg
-4845.03%
Market Cap
$15.65M
Operating Margin
-3939.06%
TTM Avg
-1969.53%
3Y Avg
-984.76%
5Y Avg
-656.51%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.75M | -116.95% | -109.11% | -183.65% | -324.52% |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | -65.74% | -32.87% | -308.88% | 2329.03% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.53M | -1315.38% | -3051.53% | -1759.85% | -1656.14% |
| PAVmed Inc. (PAVM)vs › | $17.04M | -30712.68% | -16099.03% | -14791.19% | -11673.89% |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | -579.88% | -374.35% | -344.88% | -436.34% |
| Lipocine Inc. (LPCN)vs › | $17.11M | -524.69% | -267.50% | -582.47% | -385.07% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.17M | 0.00% | -84.34% | -293.08% | -1756.66% |
| BioCardia, Inc. (BCDA)vs › | $15.93M | 0.00% | -6897.41% | -4279.04% | -4845.03% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.65M | -3939.06% | -1969.53% | -984.76% | -656.51% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
21.9%
Operating Margin
-117.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -88.34% |
| 2026-03-31 | -118.09% |
| 2025-12-31 | -107.36% |
| 2025-09-30 | -115.90% |
| 2025-06-30 | -115.85% |
| 2025-03-31 | -131.10% |
| 2024-12-31 | -146.28% |
| 2024-09-30 | -722.89% |
| 2024-06-30 | -218.99% |
| 2024-03-31 | -354.92% |
| 2023-12-31 | -186.87% |
| 2023-09-30 | -1214.98% |
| 2023-06-30 | -436.49% |
| 2023-03-31 | -510.36% |
| 2022-12-31 | -456.81% |
| 2022-09-30 | -445.22% |
| 2022-06-30 | -480.94% |
| 2022-03-31 | -525.68% |
| 2021-12-31 | -456.73% |
| 2021-09-30 | -444.21% |
| 2021-06-30 | -427.28% |
| 2021-03-31 | -352.37% |
| 2020-12-31 | -278.86% |
| 2020-09-30 | -465.71% |
| 2020-06-30 | -629.02% |
| 2020-03-31 | -859.33% |
| 2019-12-31 | -256.73% |
| 2019-09-30 | -171.60% |
| 2019-06-30 | -314.73% |
| 2019-03-31 | -333.83% |
| 2018-12-31 | -151.95% |
| 2018-09-30 | -211.01% |
| 2018-06-30 | -118.35% |
| 2018-03-31 | -245.15% |
| 2017-12-31 | -184.15% |
| 2017-09-30 | -183.41% |
| 2017-06-30 | -307.83% |
| 2017-03-31 | -359.61% |
